| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | WG Critical Care, LLC | 17a400ae-cbaa-4d07-95f4-c6917dfc0585 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | Exact identifier unii: M98T69Q7HP unii: UXA545ABTT |
| Zosyn | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Baxter Healthcare Corporation | 8db6bd91-2106-4bfd-8cc8-38aaf1e18d17 | 2026-05-15 | Warnings, Adverse reactions | Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT |
| ZERBAXA | CEFTOLOZANE AND TAZOBACTAM | Merck Sharp & Dohme LLC | 70ac1d90-eff3-4f0b-9f46-5846c571b32f | 2026-05-12 | Warnings, Adverse reactions | Exact identifier unii: UXA545ABTT |
| Piperacillin and Tazobactam and Sodium Chloride | PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE | B. Braun Medical Inc. | a63ca653-27d4-45fe-a744-77e0efe45220 | 2026-05-08 | Warnings, Adverse reactions | Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Civica, Inc. | 19e89f8b-316b-4dd2-9724-bfe0faeba408 | 2025-12-12 | Warnings, Adverse reactions | Exact identifier rxcui: 1659137 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT |
| piperacillin and tazobactam | PIPERACILLIN AND TAZOBACTAM | Civica, Inc. | 7aebc0e6-89db-4ef0-b5ab-d6b3199bcfc4 | 2025-09-08 | Warnings, Adverse reactions | Exact identifier rxcui: 1659137 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Avenacy, LLC | 668a2730-e95a-4639-a506-ae95a6502ca1 | 2025-09-01 | Boxed warning, Warnings, Adverse reactions | Exact identifier unii: M98T69Q7HP unii: UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Eugia US LLC | 39e19789-de4b-4fd1-ab1c-92f59496f496 | 2025-08-19 | Warnings, Adverse reactions | Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Eugia US LLC | a5d8625e-e630-4076-bc55-46ebe861c6a5 | 2025-08-08 | Warnings, Adverse reactions | Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT |
| piperacillin and tazobactam | PIPERACILLIN AND TAZOBACTAM | ONESOURCE SPECIALTY PHARMA LIMITED | 28258745-12e4-4f0f-b318-4a1a1bebc928 | 2025-07-21 | Warnings, Adverse reactions | Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Avenacy, LLC | 9114cea1-3338-487e-87fa-cc3a409d501a | 2025-07-07 | Warnings, Adverse reactions | Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | BluePoint Laboratories | 1aba753c-d0c2-4b35-917a-9143dd4be468 | 2025-06-20 | Warnings, Adverse reactions | Exact identifier application number: ANDA204959 rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Apotex Corp. | 2c8f06a2-49b2-4169-94ef-182d13d248bf | 2025-05-21 | Warnings, Adverse reactions | Exact identifier application number: ANDA204959 ndc (package): 60505-6159-4 ndc (package): 60505-6156-0 ndc (package): 60505-6159-0 ndc (package): 60505-6157-0 ndc (package): 60505-6157-4 ndc (package): 60505-6156-4 ndc (product): 60505-6157 ndc (product): 60505-6159 ndc (product): 60505-6156 ndc11 (package): 60505615900 rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 spl id: 0702bfe3-61ba-4c3e-a9e4-ceafca2a8821 spl set id: 2c8f06a2-49b2-4169-94ef-182d13d248bf unii: M98T69Q7HP unii: UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Fresenius Kabi USA, LLC | c5cddf50-e486-4ffb-9bc6-ed67ad6bc154 | 2025-04-14 | Warnings, Adverse reactions | Exact identifier unii: M98T69Q7HP unii: UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Fresenius Kabi USA, LLC | a798faf5-cd97-4e35-a700-94c372978c46 | 2025-04-14 | Warnings, Adverse reactions | Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Fresenius Kabi USA, LLC | 6a894b94-171f-4217-81a2-0e84796b0b41 | 2025-04-11 | Warnings, Adverse reactions | Exact identifier unii: M98T69Q7HP unii: UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Fresenius Kabi USA, LLC | c8e3cc43-238d-4a23-95dc-157c85f83184 | 2025-04-10 | Warnings, Adverse reactions | Exact identifier unii: M98T69Q7HP unii: UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Provepharm Inc. | 68d5384d-1691-4afc-8a1a-488f8e2ef2c5 | 2025-02-26 | Boxed warning, Warnings, Adverse reactions | Exact identifier unii: M98T69Q7HP unii: UXA545ABTT |
| PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Provepharm Inc. | bc26ffd8-1a6e-4e16-91c1-ec67c928b3bf | 2025-02-26 | Warnings, Adverse reactions | Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Sandoz Inc | 9b682c66-61c6-4ade-baf4-9d68911a16b8 | 2024-10-30 | Warnings, Adverse reactions | Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT |